Analysts See $0.53 EPS for Hologic, Inc. (HOLX); B&amp M EUROPEAN VALUE RETAIL SA ORDINAR (BMRPF) Shorts Up By 278.12%

April 17, 2018 - By Hazel Jackson

Hologic, Inc. (NASDAQ:HOLX) Logo

Analysts expect Hologic, Inc. (NASDAQ:HOLX) to report $0.53 EPS on May, 2 after the close.They anticipate $0.03 EPS change or 6.00% from last quarter’s $0.5 EPS. HOLX’s profit would be $146.54 million giving it 17.74 P/E if the $0.53 EPS is correct. After having $0.55 EPS previously, Hologic, Inc.’s analysts see -3.64% EPS growth. The stock decreased 0.25% or $0.09 during the last trading session, reaching $37.6. About 42,553 shares traded. Hologic, Inc. (NASDAQ:HOLX) has declined 11.91% since April 17, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.

B&amp M EUROPEAN VALUE RETAIL SA ORDINAR (OTCMKTS:BMRPF) had an increase of 278.12% in short interest. BMRPF’s SI was 12,100 shares in April as released by FINRA. Its up 278.12% from 3,200 shares previously. The stock decreased 5.95% or $0.35 during the last trading session, reaching $5.53. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

B&M European Value Retail S.A. operates as a general merchandise value retailer in the United Kingdom and Germany. The company has market cap of $5.12 billion. The Company’s stores offer products in various categories, such as home furnishings and adornments, electricals, toys, clothing and footwear products, household goods, toiletries, foods, confectioneries, soft drinks, alcohol, Halloween and Christmas goods, giftware, stationery and crafts, pet care products, DIY and decorating products, and travel accessories, as well as gardening, outdoor, and leisure products. It has a 25.72 P/E ratio. The firm operates approximately 537 stores under the B&M brand in the United Kingdom; and 75 stores under the Jawoll brand in Germany.

Investors sentiment decreased to 0.74 in 2017 Q4. Its down 0.14, from 0.88 in 2017Q3. It fall, as 57 investors sold Hologic, Inc. shares while 165 reduced holdings. 70 funds opened positions while 94 raised stakes. 264.36 million shares or 0.45% less from 265.54 million shares in 2017Q3 were reported. Thrivent For Lutherans invested 0.09% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Private Advisor Grp Inc Ltd Co invested in 0.02% or 10,758 shares. Nippon Life Glob Investors Americas accumulated 88,800 shares. Raymond James Fin holds 8,610 shares or 0% of its portfolio. Employees Retirement Sys Of Texas holds 0.01% or 17,000 shares. Swiss Savings Bank reported 0.05% in Hologic, Inc. (NASDAQ:HOLX). Axa has 0.23% invested in Hologic, Inc. (NASDAQ:HOLX) for 1.39M shares. Eaton Vance reported 0.05% in Hologic, Inc. (NASDAQ:HOLX). Citigroup reported 24,344 shares. Ahl Ptnrs Llp invested in 69,689 shares or 0.05% of the stock. Blackrock reported 20.94M shares. Pub Employees Retirement Association Of Colorado invested 0.1% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Northern reported 3.58 million shares. Ftb Advsrs reported 350 shares. 10,638 are owned by Fisher Asset Mgmt Limited Liability.

Since February 13, 2018, it had 3 insider buys, and 1 sale for $682,999 activity. $199,826 worth of Hologic, Inc. (NASDAQ:HOLX) was bought by Wendell Amy McBride on Wednesday, March 14. $271,250 worth of Hologic, Inc. (NASDAQ:HOLX) shares were sold by Bebo Allison P. Dockendorff Charles J had bought 13,000 shares worth $504,400 on Wednesday, March 14. On Tuesday, February 13 the insider Nawana Namal bought $250,023.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $10.40 billion. It operates through four divisions: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It has a 9.95 P/E ratio. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test.

Hologic, Inc. (NASDAQ:HOLX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Hazel Jackson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts